Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Shanshan Xu is See remarks at Bambusa Therapeutics. OQRO lists 10 transactions filed with the SEC under this name, the latest on Nov 2, 2026, each linked to the official Form 4.
See remarks
Disclosures on record
10
Companies involved
1
Bambusa TherapeuticsBBTX
10 disclosures · Nov 2026
Oct 29, 2026379Kdisclosed Nov 2
DetailsOfficial recordOct 29, 2026758Kdisclosed Nov 2
DetailsOfficial recordNov 2, 202616K
DetailsOfficial recordNov 2, 2026147K
DetailsOfficial recordNov 2, 20264,155
DetailsOfficial recordNov 2, 202610K
DetailsOfficial recordNov 2, 20261,753
DetailsOfficial recordNov 2, 202637K
DetailsOfficial recordNov 2, 202694K
DetailsOfficial recordNov 2, 202616K
DetailsOfficial recordAs of the latest filing on , Shanshan Xu reported holding 7,562,518 shares of Bambusa Therapeutics (BBTX), worth about $122M at the last close of $16 (Nov 13, 2026), held through a see footnote.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Bambusa Therapeutics BBTX | 7,562,518 | 7.56M see footnote | $16 | $122M | Nov 2, 2026 |
Is this Shanshan Xu’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Nov 2, 2026, Shanshan Xu reported holding 7,562,518 shares of Bambusa Therapeutics (BBTX), held indirectly. At the last close of $16 on Nov 13, 2026, that is about $122M. This is the stake disclosed in filings, not a net worth.